Skip to main content

Table 1 Patient characteristics and PET information

From: The feasibility of [18F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study

Nr. Age at diagnosis (years) Weight (kg) Histology Stage MTV (cm3) Hypoxia in [18F]EF5 PET/CT Hypoxic subvolume (cm3, % of MTV) Injected [18F]EF5 activity (Mbq)
1 62 106 high grade serous IIIC 571 yes 364 (64%) 381
2 56 81 endometrioid IIB 250 yes 121 (49%) 367
3 65 100 sarcoma IIB 1908 yes 42 (2%) 374
4 38 93 mucinous IA 158 no   367
5 73 54 carcinosarcoma IIIC 267 yes 17 (6%) 301
6 79 68 high grade serous IVB 615 yes 202 (33%) 220
7 67 63 high grade serous IIIC 955 no   385
8 56 70 fibroma - 224 no   377
9 50 103 clear cell IIIC 116 no   378
10 69 77 high grade serous IVA 324 no   380
11 45 91 serous BOT IA 66 no   374
12 65 69 high grade serous IIIC 273 no   377
13 50 152 endometrioid IIA 173 no   363
14 68 59 high grade serous IIIC 1288 yes 87 (7%) 362
15 64 60 endometrioid IIA 346 yes 33 (10%) 177
  1. BOT borderline ovarian tumor, MTV metabolic tumor volume, HSV hypoxic subvolume